CURE’s head & neck cancer page is a go-to resource for oncology news and updates in the world of head & neck cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight to the latest treatments and research in head & neck cancer.
October 19th 2024
Patients with a head and neck cancer subtype did not show differences in survival outcomes when treated with radiation versus transoral robotic surgery.
LOXO-292 Granted Breakthrough Therapy Designation for Lung and Thyroid Cancer
September 5th 2018The FDA has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with RET fusion–positive non–small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC). This designation will expedite the development and review of the drug.
A Closer Look at Long-Term Outcomes in Young Cancer Survivors
July 10th 2018The majority of adolescent and young adult (AYA) patients who are diagnosed with cancer are expected to live past the five-year mark, though survival and health outcomes seem to differ by disease type, according to recent research published in the journal Cancer.
Cancer Rates 'Soar' in Flight Crew Compared with General Population
July 4th 2018While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.
Gender May Play a Role in Immunotherapy Efficacy, Further Studies Are Warranted
June 29th 2018Because little is known about the effect of patients' sex on the efficacy of immune checkpoint inhibitors as cancer treatments, the researchers performed a systematic review and meta-analysis to determine the heterogeneity of immune checkpoint inhibitor efficacy between men and women.
Technology May Decrease Symptom Burden in Head and Neck Cancer Survivors
May 21st 2018Patients with head and neck cancer experienced a decrease in symptom severity after using mobile and sensor technology that allowed their health care providers to remotely monitor symptoms, according to research that will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
FDA Approves Combination for Rare Thyroid Cancer Type
May 4th 2018The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.
Number of Cancerous Lymph Nodes May Predict Head and Neck Cancer Survival
March 1st 2018A variety of factors go in to the staging of a head and neck cancer diagnosis, however, the number of malignant lymph nodes may very well be the key to prognosis and treatment moving forward in this patient population.